Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. 1:15-cv-00079; Filed: 01/23/2015;
Case Updated Daily; Latest Docket Entry: 10/03/2016; PACER. Create Alert. ×.
Jan 13, 2016 ... INC., C.P. PHARMACEUTICALS INTERNATIONAL. C.V., PFIZER
PHARMACEUTICALS LLC,. PF PRISM C.V.,. Plaintiffs-Appellees v. MYLAN ...
Feb 1, 2015 ... Otsuka Pharmaceutical Co. Ltd. v. Apotex Inc. et al. 1:15-cv-00109; ... Mylan
Pharmaceuticals Inc. ... Plaintiffs: Pfizer Inc.; UCB Pharma GmbH
Jun 25, 2012 ... ... et al., Pfizer Inc. et al. v. Lupin Ltd. et al., Pfizer Inc. et al. v. Mylan
Pharmaceuticals Inc. et al., Pfizer Inc. et al. v. Roxane Laboratories Inc. et al.
... case centered on patent quality. Pfizer Inc. et al. v. Alphapharm Pty. Ltd. et al. ...
Ltd. and its U.S. affiliate Mylan Pharmaceuticals Inc. over their plans to release ...
Aug 31, 2016 ... et al., Case No. 6:13-cv-252 (E.D. Tex.); Wi-LAN. Inc. v. Apple Inc. ...... Pfizer, Inc.
and UCB Pharma GMBH v. Mylan. Pharmaceuticals, Inc., No.
Oct 22, 2014 ... A Delaware federal judge ruled Wednesday that Pfizer Inc.'s patent for cancer
drug Sutent was nonobvious and could stand, despite a challenge from Mylan
Pharmaceuticals Inc. in Pfizer's suit seeking to ... The case is Pfizer Inc. et al. v.
Mylan Inc. et al., case number 1:10-cv-00528, in the U.S. District Court ...
In the case of FTC v. Actavis, Inc., 133 S.Ct. 2223 (2013), the U.S. Supreme Court
.... USA, Inc. • AstraZeneca AB et. al., v. ... Inc. v. Sun Pharmaceutical Industries,
Inc., et. al. ... Pfizer, Inc., et. seq. v. Purepac ... UK, Ltd. v. Mylan Inc., et. al.
Actavis Laboratories UT, Inc. v. Par Pharmaceutical, Inc., No. :115-cv-886 (D. Del.
) Noven Pharmaceuticals, Inc. v. Mylan Technologies Inc., et al., No.
He focuses his practice on representing generic pharmaceutical companies in
Hatch-Waxman patent ... Merck Sharp & Dohm Corp. et al. v. ... Mylan Pharms. ...
InnoPharma, Inc. et al., 12–260 (RGA) (CJB) (D. Del.) ... Pfizer, Inc.,AAA Case No.